Skip to main content
. 2006 Apr 19;2006(2):CD006018. doi: 10.1002/14651858.CD006018

Otto 2001 (unpublished).

Methods RCT 
 1993‐1999
Participants 108 
 T3, N1‐2, M0
Interventions Surgery + Adjuvant CT vs. Surgery alone
Cisplatin 70mg/m2 
 Methotrexate 30mg/m2 
 Vinblastine 3mg/m2 
 Epirubicin 45mg/m2 
 3 x 4‐weekly cycles
Outcomes Survival
Notes Unpublished
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate